Catalyst Event
Abbott Laboratories (ABT) · Other
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
3/24/2026, 12:00:00 AM
S&P Global Ratings is expected to downgrade Abbott's credit rating to 'A+' from 'AA-' on March 24, 2026, following the Exact Sciences acquisition; market analysts estimate a >=10% price impact.
Korean Translation
2026년 3월 24일 S&P 글로벌 레이팅스는 Exact Sciences 인수에 따른 부채 증가를 이유로 Abbott의 신용등급을 'AA-'에서 'A+'로 하향 조정할 예정임. 시장 분석가들은 10% 이상의 주가 영향을 예상함.
Related Recent Events
DICK'S Sporting Goods Inc (DKS) · Earnings Release
First quarter 2026 earnings release is scheduled.
5/27/2026, 12:00:00 AM
Planet Fitness Inc (PLNT) · Earnings Release
Q1 2026 earnings release on 2026-05-07 is scheduled. A typical 1-2% price movement is estimated.
5/7/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
First quarter 2026 financial results announcement scheduled.
5/6/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
First quarter 2026 earnings release and conference call, which is estimated to have a >=10% price impact, is scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck will report Q1 2026 earnings and host its earnings call on 2026-04-30, which is likely to be material given the strong market sensitivity to its recent guidance outlook, scheduled.
4/30/2026, 12:00:00 AM
Novartis AG (NVS) · Earnings Release
First quarter 2026 earnings results, with low impact expected from the date announcement, scheduled
4/28/2026, 12:00:00 AM